Login to Access Video or Poster Abstract: MP02-03
Sources of Funding: none

Introduction

To evaluate for the first time long-term outcomes after Photovaporization of the prostate (PVP) with the XPS Greenlight® laser (GL-XPS) in patients with symptomatic benign prostatic hyperplasia (BPH).

Methods

A prospective study was performed of all patients with symptomatic BPH who underwent GL-XPS vaporization at our institution between September 2010 and September 2012. Functional outcomes with at least 48 months of follow-up were evaluated by questionnaire. Long term rate of complications and /or reoperation were assessed. Prostate Specific Antigen(PSA) level was measured at 3, 12 and 48 months of follow up.

Results

The response rate of the long terms questionnaire was high, 82 %. 84 patients with full data were included. Mean follow-up was 57,4±6,8 months. Mean International Prostate Symptoms Score (IPSS) decreased significantly from 19,9±6,4 preoperatively to 8,2±5,7, 6,16±5,6, and 3,94±3,4 at 1, 3 and 12 months respectively. Mean IPPS remained stable at 5,9±5,8 after 48 months. The mean PSA level has reduced significantly, from 4,5±4,31ng/mL preoperatively. to 2,00±2,13ng/mL, 2,08±2,08ng/mL and 2,66±2,27ng/mL respectively at 3, 12 and 48 months. Urinary parameters were significantly improved. Mean Qmax increased from 9,6±3,8 mL/s preoperatively to 21,8±11,3 mL/s, 23,9±11,5mL/s at 1 and 3 months respectively and remained stable at 12 months at 25,2±9,2mL/s. The satisfaction rate was high, 88% after a mean follow-up of 57,4 months. Two patients required reoperation due to recurrent BPO and two others for bladder neck contracture.

Conclusions

PVP with the GL-XPS is a safe and effective laser technique at improving durably IPSS in patients with symptomatic BPH.

Funding

none